Wellington Biomedical Innovation Master Investors Cayman I

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Wellington Biomedical Innovation Master Investors Cayman I
CIK #0001903360, 0001787092
EDGAR Form CIK 2011 - 2026
3 [0001787092]
4 [0001787092]
D [0001787092]
SC 13G [0001787092]
3 [0001903360]
4 [0001903360]
SC 13G [0001903360]
Form 13D/13G Filer Form 13D/13G Subject Filed
Wellington Biomedical Innovation Master Investors Cayman II LP Promis Neurosciences Inc [2026-03-18]
Wellington Biomedical Innovation Master Investors Cayman II LP MBX Biosciences Inc [2024-09-20]
Wellington Biomedical Innovation Master Investors Cayman I LP Verve Therapeutics Inc [2021-06-28]
Wellington Biomedical Innovation Master Investors Cayman I LP Aligos Therapeutics Inc [2020-10-22]
Form 3/4/5 Subject 2011 - 2026
Avalyn Pharma Inc
Wellington Biomedical Innovation Master Investors Cayman I
Metsera Inc
Upstream Bio Inc
Wellington Biomedical Innovation Master Investors Cayman I
Zenas BioPharma Inc
MBX Biosciences Inc
Artiva Biotherapeutics Inc
Boundless Bio Inc
CARGO Therapeutics Inc
RayzeBio Inc
Acrivon Therapeutics Inc
Nuvalent Inc
Verve Therapeutics Inc
Edgewise Therapeutics Inc
Olema Pharmaceuticals Inc
Aligos Therapeutics Inc
PMV Pharmaceuticals Inc
Dyne Therapeutics Inc
Kymera Therapeutics Inc
Nurix Therapeutics Inc
Forma Therapeutics Holdings LLC
Generation Bio Co
Black Diamond Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Metsera Inc MTSR
Series B Preferred Stock · derivative
2025-01-30 Conversion 4,365,079 $0.00
Metsera Inc MTSR
Common Stock
2025-01-30 Conversion 1,857,699
Upstream Bio Inc UPB
Series B redeemable convertible preferred stock · derivative
2024-10-15 Conversion 852,940 $0.00
Upstream Bio Inc UPB
Common Stock
2024-10-15 Conversion 894,733
MBX Biosciences Inc MBX
Common Stock
2024-09-16 Conversion 1,386,335
MBX Biosciences Inc MBX
Common Stock
2024-09-16 Conversion 403,787
MBX Biosciences Inc MBX
Series C Preferred Stock · derivative
2024-09-16 Conversion 4,854,368 $0.00
Zenas BioPharma Inc ZBIO
Common Stock
2024-09-16 Conversion 420,271
Zenas BioPharma Inc ZBIO
Common Stock
2024-09-16 Conversion 180,635
Zenas BioPharma Inc ZBIO
Common Stock
2024-09-16 Conversion 200,718
Zenas BioPharma Inc ZBIO
Series A Convertible Preferred Stock · derivative
2024-09-16 Conversion 1,568,480
Zenas BioPharma Inc ZBIO
Series C Convertible Preferred Stock · derivative
2024-09-16 Conversion 1,742,858
Zenas BioPharma Inc ZBIO
Series B Convertible Preferred Stock · derivative
2024-09-16 Conversion 3,649,263
MBX Biosciences Inc MBX
Series B Preferred Stock · derivative
2024-09-16 Conversion 16,666,666 $0.00
Artiva Biotherapeutics Inc ARTV
Common Stock
2024-07-22 Other 49,019 $10.20 499,994
Artiva Biotherapeutics Inc ARTV
Common Stock
2024-07-22 Conversion 145,089
Artiva Biotherapeutics Inc ARTV
Series B Preferred Stock · derivative
2024-07-22 Conversion 145,089
Boundless Bio Inc BOLD
Common Stock
2024-04-02 Conversion 366,300
Boundless Bio Inc BOLD
Common Stock
2024-04-02 Conversion 189,933
Boundless Bio Inc BOLD
Series C Preferred Stock · derivative
2024-04-02 Conversion 7,142,857 $0.00
showing 20 of 59 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com